Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma may improve embryo genetics in IVF.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Higher iron levels in the blood are not linked to increased hair loss in women.

Finasteride 2.5 mg/day can effectively treat female hair loss.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Menopause affects hair and skin; more research needed for treatment.

Iron deficiency is common in women regardless of hair loss, and treating it does not usually reverse hair loss.

Finasteride at 2.5mg/day may help postmenopausal women with hair loss.

Antiandrogenic drugs could be a good treatment option for frontal fibrosing alopecia.

Melatonin may improve some hormonal and inflammatory issues in women with PCOS.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

Exercising women should be screened for anemia due to its prevalence and impact on performance.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Most women lack knowledge about androgens and their excess symptoms.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Women with PCOS may have a higher risk of Alzheimer's disease.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Women under 55 with hair loss (AGA) may have a higher risk of heart disease (CAD).